The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Whole-body MRI (WB-MRI) combined with 18F-FDG PET/CT does not improve staging accuracy for advanced non-small cell lung cancer (NSCLC) compared to standard brain MRI. This finding suggests current imaging protocols may not require the addition of WB-MRI for these patients.
Area Of Science
- Oncology
- Radiology
- Medical Imaging
Background
- Advanced non-small cell lung cancer (NSCLC) has a poor prognosis.
- 18F-FDG PET/CT is standard for staging NSCLC but has limited specificity.
- The added value of whole-body MRI (WB-MRI) for NSCLC staging is debated.
Purpose Of The Study
- To evaluate the utility of WB-MRI in addition to 18F-FDG PET/CT for staging advanced NSCLC.
- To compare WB-MRI with standard brain MRI in the staging work-up of NSCLC patients.
- To determine if WB-MRI enhances the detection and characterization of malignant lesions in advanced NSCLC.
Main Methods
- Prospective single-center study of 28 NSCLC patients (Stage 3 or oligometastatic).
- Patients underwent 18F-FDG PET/CT and WB-MRI (including thorax, abdomen, spine, pelvis, contrast-enhanced brain and liver).
- Separate blinded readings of imaging followed by consensus; 12-month follow-up as reference standard.
Main Results
- WB-MRI and 18F-FDG PET/CT showed similar sensitivity and specificity for primary tumor and distant metastasis detection.
- WB-MRI demonstrated lower sensitivity (0.65) than 18F-FDG PET/CT (1.00) for lymph node metastases (p < 0.05).
- Specificity for lymph node metastases was similar between WB-MRI and 18F-FDG PET/CT (p = 0.59).
Conclusions
- Whole-body MRI (WB-MRI) in conjunction with 18F-FDG PET/CT offers no additional staging value over brain MRI alone for advanced NSCLC.
- The time-consuming nature of WB-MRI may not be justified for routine NSCLC staging.
- Standard staging protocols using 18F-FDG PET/CT and brain MRI appear sufficient for advanced NSCLC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radioactive Tracer: PET involves using biologically active molecules labeled with radioactive isotopes, known as tracers or radiotracers. The...
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...